Our Mission

To improve diversity in clinical trials across our institutions, CTSI is identifying specific areas for improvement, designing and developing joint interventions, using uniform metrics to measure outcomes, and establishing best practices that can be shared with the CTSA network.

Our Aims

  1. Language Justice: Ensuring that clinical trials receive informed consent in the correct language and have access to appropriate interpretation at different phases of the study.
    • Developing Pathways across California to leverage verified  translation resources
    • Collaboration with the Health System
  2. Trial Equity: Ensuring underrepresented individuals are included and have access to clinical trials.
    • Work with Partner Sites and Community Partners to ensure clinical trial infrastructure to support trials is more widely available and accessible
    • Research Themes and Topics that address the needs of the Community
  3. Trial Diversity & Inclusion: Enhance the inclusion of a diverse population representative of Los Angeles on clinical trials.
    • JEDI Training for Research PIs and Clinical Research Coordinators to ensure access and address bias
    • Community Educational Design Campaign around the What and Why of Clinical Trials
    • Do inclusion/exclusion criteria restrict specific communities

Highlighting Ongoing Work across the Hub

LABEST 2023 Presentations

See below to view a snapshot of the presentations showcased at this year's LABEST conference.

Improving Access to Clinical Trials for Underrepresented Populations: Patient Focused Initiatives
Clinical Trials  Outreach Campaigns

Improving Access to Clinical Trials for Underrepresented Populations: Patient Focused Initiatives

Presented by: Maria Garcia-Jimenez, MD/MHS & Sylvia Lopez Ferullo, MPH, CHES

Clinical Trials Outreach Campaigns

Presented by: Zul Surani

Cost of consent document translation as a barrier to clinical trial participation
C3PO Reflections

Cost of consent document translation as a barrier to clinical trial participation

Presented by: Maria A Velez, MD

C3PO Reflections

Presented by: Kabir Yadav, MDCM MS MSHS


 

Improving Representation in Clinical Trials Research

Aligning with the NASEM initiative

View the full NASEM Report

Leadership

Arleen Brown

Arleen Brown, MD, PhD

CTSI Co-Director, Community Engagement and Research Program Leader, CEDER MPI & Community and Collaboration Engagement Studio Core Co-Lead
Arash Naeim

Arash Naeim, MD, PhD

Clinical & Translational Science Institute Co-Director, Senior Associate Director (Clinical Research), Network Capacity Program Leader, Participant and Clinical Interactions Program Leader, Regulatory Knowledge and Support Program Leader